Investigation of the safety and effectiveness of combination therapy of donepezil hydrochloride and memantine hydrochloride in patients with Alzheimer's Disease
Not Applicable
- Conditions
- Alzheimer's Disease
- Registration Number
- JPRN-jRCT1080222139
- Lead Sponsor
- Eisai Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 5000
Inclusion Criteria
Patients diagnosed as Alzheimer's Disease who are to be administered both donepezil hydrochloride and memantine hydrochloride for the first time
Exclusion Criteria
Patients with a history of hypersensitivity to any ingredients of Aricept or piperidine derivatives.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method